The novel approach of this peptide represents a exciting advance in the management of type 2 diabetes. Distinct from existing therapies, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide185727.timeblog.net/77924822/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment